<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04191057</url>
  </required_header>
  <id_info>
    <org_study_id>18-25508</org_study_id>
    <nct_id>NCT04191057</nct_id>
  </id_info>
  <brief_title>Determining Normal Range for Free Light Chains in Serum Among Twins</brief_title>
  <official_title>Normal Range Study for Free Light Chains in Blood Among Identical or Fraternal Twins</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to recruit healthy adult identical and fraternal twins for the
      collection of one teaspoon of blood to be sent to the Clinical Lab at San Francisco General
      Hospital. The serum will be tested to determine the reference range for free light chains.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Serum free light chains are used to assist in the diagnosis of multiple myeloma. The test
      measures kappa (K) and lambda (L) chains, and the calculation of the ratio of kappa to lambda
      (K/L). Previous studies have shown that the K/L ratio does not change over time (1 year). The
      hypothesis of this study is that healthy twins will have a K/L ratio that are close to each
      other in value, suggesting that this ratio is geneticallyl linked.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 15, 2018</start_date>
  <completion_date type="Anticipated">January 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The participant will not be given the results of the free light chain result</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Free light chain reference range</measure>
    <time_frame>One month after the completion of the enrollment</time_frame>
    <description>Determination of the normal range for free light chains</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Multiple Myeloma</condition>
  <arm_group>
    <arm_group_label>Healthy twin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Free light chains of twins compared to non-twin siblings</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Free light chains</intervention_name>
    <description>Blood samples will be collected and analyzed</description>
    <arm_group_label>Healthy twin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects 18-80 years.

          -  Must be an identical or fraternal twin (both must be recruited)

        Exclusion Criteria:

          -  Symptoms suggestive of multiple myeloma (e.g., renal insufficiency, anemia, bone pain)
             -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Wu, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alan Wu, PhD</last_name>
    <phone>628-206-3540</phone>
    <email>alan.wu@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bee Ong</last_name>
    <phone>628-206-4239</phone>
    <email>chuimei.ong@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>San Francisco General Hospital</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94306</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Wu, Ph.D.</last_name>
      <phone>628-206-3540</phone>
      <email>alan.wu@ucsf.edu</email>
    </contact>
    <contact_backup>
      <last_name>Bee Ong</last_name>
      <phone>628-206-4239</phone>
      <email>chuimei.ong@ucsf.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Braga F, Infusino I, Dolci A, Panteghini M. Biological variation of free light chains in serum. Clin Chim Acta. 2013 Jan 16;415:10-1. doi: 10.1016/j.cca.2012.09.008. Epub 2012 Sep 11.</citation>
    <PMID>22981867</PMID>
  </results_reference>
  <results_reference>
    <citation>Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002 Sep;48(9):1437-44.</citation>
    <PMID>12194920</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 5, 2019</study_first_submitted>
  <study_first_submitted_qc>December 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2019</study_first_posted>
  <last_update_submitted>December 5, 2019</last_update_submitted>
  <last_update_submitted_qc>December 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>free light chains</keyword>
  <keyword>healthy twins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Myeloma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Participants and other researchers will not have access to data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

